Avanos Medical (AVNS) Proxy Filing summary

Voting matters and shareholder proposals

• Election of five directors to serve until the 2026 Annual Meeting, with all nominees recommended for approval.

• Ratification of Deloitte & Touche LLP as independent registered public accounting firm for 2025.

• Advisory vote to approve named executive officer compensation (say-on-pay).

• Approval of an amendment to the 2021 Long Term Incentive Plan, increasing shares reserved by 2,250,000.

Board of directors and corporate governance

• Director nominees include Gary D. Blackford, Dr. Lisa Egbuonu-Davis, Indrani L. Franchini, Patrick J. O'Leary, and Dr. Julie Shimer.

• All nominees are recommended by the board for election.

Executive compensation and say-on-pay

• Advisory vote scheduled to approve compensation for named executive officers.

• Proposal to amend the 2021 Long Term Incentive Plan to increase share reserve by 2,250,000 shares.